People are running their own experiments with GLP-1s — with stunning results episode artwork

EPISODE · Jul 16, 2026 · 25 MIN

People are running their own experiments with GLP-1s — with stunning results

from Apple News In Conversation

GLP-1 drugs like Ozempic and Wegovy are being taken by millions of Americans. These medications have been approved for treating diabetes, obesity, and a small number of other chronic conditions. But even as experts are still learning how the drugs work, many people have found that they help with other disorders — from addiction to brain fog to arthritis — where anecdotal evidence is promising but the formal research hasn’t caught up. Julia Belluz, a contributing writer for the New York Times Opinion section and coauthor of Food Intelligence, joins Apple News In Conversation guest host David Greene to explain why what’s unfolding right now may be the largest uncontrolled drug experiment in modern history.

Episode metadata supplied by the publisher feed · Published Jul 16, 2026

Embed this episode

NOW PLAYING

People are running their own experiments with GLP-1s — with stunning results

0:00 25:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Apple News In Conversation?

This episode is 25 minutes long.

When was this Apple News In Conversation episode published?

This episode was published on July 16, 2026.

Can I download this Apple News In Conversation episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!